E684-0374 Screening compound: 1-(5-{[4-(2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-1-ylcarbonyl)piperidino]sulfonyl}-2-methyl-2,3-dihydro-1H-indol-1-yl)-1-ethanone

E684-0374 Screening compound: 1-(5-{[4-(2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-1-ylcarbonyl)piperidino]sulfonyl}-2-methyl-2,3-dihydro-1H-indol-1-yl)-1-ethanone
E684-0374 Screening compound: 1-(5-{[4-(2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-1-ylcarbonyl)piperidino]sulfonyl}-2-methyl-2,3-dihydro-1H-indol-1-yl)-1-ethanone alternative view

Chemical Structure Depiction of ChemDiv screening compound E684-0374
1-(5-{[4-(2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-1-ylcarbonyl)piperidino]sulfonyl}-2-methyl-2,3-dihydro-1H-indol-1-yl)-1-ethanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E684-0374

Molecular Formula

C26H29N5O4S (C26 H29 N5 O4 S)

Compound Name

1-(5-{[4-(2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-1-ylcarbonyl)piperidino]sulfonyl}-2-methyl-2,3-dihydro-1H-indol-1-yl)-1-ethanone

IUPAC name

1-{2-methyl-5-[(4-{257-triazatricyclo[6.4.0.0^{26}]dodeca-1(8)6911-tetraene-5-carbonyl}piperidin-1-yl)sulfonyl]-23-dihydro-1H-indol-1-yl}ethan-1-one

SMILES

CC(C1)N(C(C)=O)c(cc2)c1cc2S(N(CC1)CCC1C(N1c2nc(cccc3)c3n2CC1)=O)(=O)=O

InChI

InChI=1S/C26H29N5O4S/c1-17-15-20-16-21(7-8-23(20)31(17)18(2)32)36(34,35)28-11-9-19(10-12-28)25(33)30-14-13-29-24-6-4-3-5-22(24)27-26(29)30/h3-8,16-17,19H,9-15H2,1-2H3/t17-/m1/s1

InChI Key

SPKOLLBPZIPIKI-QGZVFWFLSA-N

MDL Number (MFCD)

MFCD14909864

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

507.61

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.013

Distribution Coefficient, logD

2.244

Water Solubility, LogSw

-3.39

Polar Surface Area

72.913

Acid Dissociation Constant (pKa)

23.29

Base Dissociation Constant (pKb)

8.09

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

42.30

E684-0374 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

Nucleic Acid Ligands (8311 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E684-0374 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E684-0374?
Check Price and Availability of E684-0374, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E684-0374 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E684-0374
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E684-0374
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E684-0374 available by request